Once-Yearly Lenacapavir Looks Promising for HIV PrEP – POZ

1. Once-Yearly Lenacapavir Looks Promising for HIV PrEP  POZ
2. Scientists develop yearly HIV injection: How it could help millions  The Times of India
3. Lenacapavir plus broadly neutralising antibodies could be twice-yearly HIV treatment  aidsmap
4. Gilead Sciences’ annual HIV prevention injection shows promise in clinical trial, Lancet study reveals  The Financial Express
5. Pharmacokinetics and safety of once-yearly lenacapavir: a phase 1, open-label study  The Lancet

 Once-Yearly Lenacapavir Looks Promising for HIV PrEP  POZScientists develop yearly HIV injection: How it could help millions  The Times of IndiaLenacapavir plus broadly neutralising antibodies could be twice-yearly HIV treatment  aidsmapGilead Sciences’ annual HIV prevention injection shows promise in clinical trial, Lancet study reveals  The Financial ExpressPharmacokinetics and safety of once-yearly lenacapavir: a phase 1, open-label study  The Lancet  Top stories – Google News